Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700683 · ClinicalTrials.gov registry record · NA
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome
A NA study, sponsored by Noctrix Health.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04700683 is a NA study that has completed, run by Noctrix Health. The registered enrollment target is 43 participants.
The verdict
NCT04700683, a NA study, has completed, sponsored by Noctrix Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
Prospective multi-site randomized sham-controlled crossover feasibility study evaluating tolerability and efficacy of noninvasive peripheral nerve stimulation (NPNS) for patients with moderate-severe primary Restless Legs Syndrome (RLS). Response to NPNS investigational device was compared to sham control in a 2x2 crossover design such that subjects were assigned to receive 2 weeks of NPNS and 2 weeks of sham, in randomized order.
Interventions
- DEVICE Noctrix Health NPNS device v1.0 - Active
- DEVICE Noctrix Health NPNS device v1.0 - Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-07-14 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04700683
The ClinicalTrials.gov registry entry for NCT04700683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noctrix Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Noctrix Health NPNS device v1.0 - Active is the first listed.
NCT04700683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04700683 about?
NCT04700683 is a clinical study titled "Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome". Prospective multi-site randomized sham-controlled crossover feasibility study evaluating tolerability and efficacy of noninvasive peripheral nerve stimulation (NPNS) for patients with moderate-severe primary Restless Legs Syndrome (RLS). Response to NPNS investigational device was compared to sham c...
What is the current status of trial NCT04700683?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-07-14. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04700683?
The interventions under investigation include: Noctrix Health NPNS device v1.0 - Active (DEVICE), Noctrix Health NPNS device v1.0 - Sham (DEVICE).
Who is sponsoring clinical trial NCT04700683?
This trial is sponsored by Noctrix Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.